Page 237 - 2021 IDMT Digital

NAUSEA and VOMITING CONTINUED
Assessment:
• 'LIIHUHQWLDO UHODWHG WR SRVVLEOH HWLRORJ\
o 9LUDO JDVWURHQWHULWLV GLDUUKHD FRPPRQ EXW RQVHW RI YRPLWLQJ EHIRUH SDLQ PDNHV
DSSHQGLFLWLV OHVV OLNHO\ XVXDOO\ PLOG DQG VHOI OLPLWLQJ SDLQ LV XVXDOO\ ELODWHUDO
o %DFWHULDO JDVWURHQWHULWLV GLDUUKHD ZLWK PRUH VHYHUH V\PSWRPV PD\ KDYH D IHYHU
DQG EORRG\ GLDUUKHD
o *DVWULWLV LQIODPPDWLRQ RI WKH JDVWULF PXFRVD
o '\VSHSVLD SDLQ DQG disFRPIRUW FHQWHUHG LQ WKH XSSHU DEGRPHQ GRHV QRW LQYROYH
UHIOX[ V\PSWRPV
o *(5' UHIOX[ RI VWRPDFK FRQWHQWV FDXVLQJ KHDUWEXUQ V\PSWRPV

Plan:
• 0LOG 6\PSWRPV
o $QWLHPHWLF mHGLFDWLRQV
ƒ 2QGDQVHWURQ
ƒ Promethazine (PO) - observe for potential side effects
• 6HYHUH 6\PSWRPV
o ,9 RQGDQVHWURQ
o ,9 K\GUDWLRQ
o 3RVVLEOH (9$& RU WUDQVIHU
Patient Education:
• 'LHW
o ,QJHVW FOHDU OLTXLGV EURWKV WHD VRXSV FDUERQDWHG EHYHUDJHV
o ,QJHVW VPDOO TXDQWLWLHV RI GU\ IRRGV VRGD FUDFNHUV
• )ROORZ XS $FWLRQV
o 5HWXUQ IRU IXUWKHU HYDOXDWLRQ LI V\PSWRPV GR QRW LPSURYH ZLWKLQ KRXUV
Preceptor Directive:
• Green Directive: Routine Review by Preceptor IAW AFI 44-10
• Blue Directive: Contact Preceptor Immediately for severe symptoms

[ 236 ]